142 related articles for article (PubMed ID: 36448646)
41. Lymph node density in retroperitoneal lymph node dissection as a novel marker for predicting recurrence in patients with germ cell testicular cancer: A case-control study and long-term clinical experience of a tertiary referral hospital.
Sarikaya S; Karsiyakali N; Kaya E; Topuz B; Ebiloglu T; Zor M
Actas Urol Esp (Engl Ed); 2021; 45(1):30-38. PubMed ID: 33010987
[TBL] [Abstract][Full Text] [Related]
42. Retroperitoneal Lymph Node Dissection: Perioperative Management and Updates on Surgical Techniques.
Zeng J; Cary C; Masterson TA
Urol Clin North Am; 2024 Aug; 51(3):407-419. PubMed ID: 38925743
[TBL] [Abstract][Full Text] [Related]
43. Desperation Postchemotherapy Retroperitoneal Lymph Node Dissection for Metastatic Germ Cell Tumors.
Carver BS
Urol Clin North Am; 2015 Aug; 42(3):343-6. PubMed ID: 26216821
[TBL] [Abstract][Full Text] [Related]
44. Outcomes of post-chemotherapy robot-assisted retroperitoneal lymph node dissection in testicular cancer: multi-institutional study.
Abdul-Muhsin H; Rocco N; Navaratnam A; Woods M; L'Esperance J; Castle E; Stroup S
World J Urol; 2021 Oct; 39(10):3833-3838. PubMed ID: 33959785
[TBL] [Abstract][Full Text] [Related]
45. Laparoscopic retroperitoneal lymph node dissection for stage I nonseminomatous germ cell testis tumors: the first case series in Iran.
Ziaee SA; Tabibi A; Sharifiaghdas F; Ghahestani SM; Zare S; Samzadeh M
Urol J; 2011; 8(1):27-30. PubMed ID: 21404199
[TBL] [Abstract][Full Text] [Related]
46. Is modified retroperitoneal lymph node dissection alive for clinical stage I non-seminomatous germ cell testicular tumor?
Basiri A; Ghaed MA; Simforoosh N; Tabibi A; Danesh A; Nouralizadeh A; Parizi MK
Urol J; 2013; 10(2):873-7. PubMed ID: 23801470
[TBL] [Abstract][Full Text] [Related]
47. Primary retroperitoneal lymph node dissection in patients with clinical stage IS testis cancer.
Williams SB; Steele GS; Richie JP
J Urol; 2009 Dec; 182(6):2716-20. PubMed ID: 19836777
[TBL] [Abstract][Full Text] [Related]
48. Distribution of nodal metastases after chemotherapy in nonseminomatous testis cancer: a possible indication for limited dissection.
Ehrlich Y; Yossepowitch O; Kedar D; Baniel J
BJU Int; 2006 Jun; 97(6):1221-4. PubMed ID: 16686715
[TBL] [Abstract][Full Text] [Related]
49. Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumors.
Wood DP; Herr HW; Heller G; Vlamis V; Sogani PC; Motzer RJ; Fair WR; Bosl GJ
J Urol; 1992 Dec; 148(6):1812-5; discussion 1815-6. PubMed ID: 1331547
[TBL] [Abstract][Full Text] [Related]
50. Clinical outcome of post-chemotherapy retroperitoneal lymph node dissection in metastatic nonseminomatous germ cell tumour: A systematic review.
Haarsma R; Blok JM; van Putten K; Meijer RP
Eur J Surg Oncol; 2020 Jun; 46(6):999-1005. PubMed ID: 32173176
[TBL] [Abstract][Full Text] [Related]
51. Is there still a place for retroperitoneal lymph node dissection in clinical stage 1 nonseminomatous testicular germ-cell tumours? A retrospective clinical study.
Dieckmann KP; Anheuser P; Kulejewski M; Gehrckens R; Feyerabend B
BMC Urol; 2018 Oct; 18(1):95. PubMed ID: 30367648
[TBL] [Abstract][Full Text] [Related]
52. Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle.
Yoon GH; Stein JP; Skinner DG
Expert Rev Anticancer Ther; 2005 Feb; 5(1):75-85. PubMed ID: 15757440
[TBL] [Abstract][Full Text] [Related]
53. Refining the laparoscopic retroperitoneal lymph node dissection for testicular cancer.
Romero FR; Wagner A; Brito FA; Muntener M; Lima GC; Kavoussi LR
Int Braz J Urol; 2006; 32(2):196-201. PubMed ID: 16650299
[TBL] [Abstract][Full Text] [Related]
54. [Comment to: "Primary laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ-cell testis tumor"].
Alcaraz A
Actas Urol Esp; 2011 Jan; 35(1):29-30. PubMed ID: 21322830
[No Abstract] [Full Text] [Related]
55. Reoperative retroperitoneal lymph node dissection for metastatic germ cell tumors: analysis of local recurrence and predictors of survival.
Pedrosa JA; Masterson TA; Rice KR; Bihrle R; Beck SD; Foster RS
J Urol; 2014 Jun; 191(6):1777-82. PubMed ID: 24518787
[TBL] [Abstract][Full Text] [Related]
56. Postchemotherapy surgery for germ cell tumors--what have we learned in 35 years?
Riggs SB; Burgess EF; Gaston KE; Merwarth CA; Raghavan D
Oncologist; 2014 May; 19(5):498-506. PubMed ID: 24718515
[TBL] [Abstract][Full Text] [Related]
57. [Laparoscopic retroperitoneal lymph node excision in clinical stage I non-seminomatous testicular cancer].
Janetschek G; Reissigl A; Peschel R; Hobisch A; Bartsch G
Urologe A; 1994 Jan; 33(1):24-30. PubMed ID: 8146927
[TBL] [Abstract][Full Text] [Related]
58. The management of non-seminomatous germ-cell tumours patients with viable malignancy at the time of RPLND.
Huddart RA
Ann Oncol; 2008 Feb; 19(2):203-4. PubMed ID: 18245130
[No Abstract] [Full Text] [Related]
59. Modified retroperitoneal lymph node dissection for post-chemotherapy residual tumour: a long-term update.
Cho JS; Kaimakliotis HZ; Cary C; Masterson TA; Beck S; Foster R
BJU Int; 2017 Jul; 120(1):104-108. PubMed ID: 28296054
[TBL] [Abstract][Full Text] [Related]
60. Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer Group.
Gerdtsson A; Håkansson U; Törnblom M; Jancke G; Negaard HFS; Glimelius I; Halvorsen D; Karlsdóttir Á; Haugnes HS; Andreassen KE; Larsen SM; Holmberg G; Wahlqvist R; Tandstad T; Cohn-Cedermark G; Ståhl O; Kjellman A
Eur Urol Oncol; 2020 Jun; 3(3):382-389. PubMed ID: 31506250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
